Literature DB >> 28165296

The activation of the kynurenine pathway in a rat model with renovascular hypertension.

Jacek Bartosiewicz1, Tomasz Kaminski1, Krystyna Pawlak2, Malgorzata Karbowska1, Anna Tankiewicz-Kwedlo2, Dariusz Pawlak1.   

Abstract

Hypertension is a serious condition that can lead to many health problems. The mechanisms underlying this process are still not fully understood. The kynurenine pathway may be involved in the occurrence and progression of hypertension. The purpose of this study was to examine the activity of peripheral kynurenine pathway in rats with renovascular hypertension in Goldblatt 2K1C model. Hypertension was induced in the experimental groups by constricting the renal artery of the left kidney of the rats. Determination of tryptophan (Trp) and kynurenine pathway metabolites was assessed by high-performance liquid chromatography in plasma and tissues obtained at 4, 8, and 16 weeks after the surgical intervention or sham surgery. Levels of Ang II were evaluated using commercial immuno-enzymatic ELISA kits. Surgical treatment led to increased values of mean blood pressure and systolic blood pressure, whereas Trp concentrations were decreased in experimental animals compared to appropriate controls. Simultaneously, the considerable increment of kynurenine pathway components and a significant increase in the activity of tryptophan 2,3-dioxygenase were observed in rats with developed hypertension in comparison with controls. There were no differences between Ang II levels in controls and experimental groups. The inverse relationship was between plasma Trp and both SBP and Ang II values, and Trp independently affected Ang II concentrations in hypertensive rats. In contrast, tryptophan 2,3-dioxygenase activity and plasma kynurenine metabolites positively correlated with blood pressure values as well as with Ang II levels in these animals. Moreover, kynurenine was independently connected with MBP. Renovascular hypertension influences kynurenine pathway and leads to an imbalance in Trp and its metabolite levels. Tryptophan 2,3-dioxygenase and part of the kynurenine metabolites in plasma and tissues positively correlated with blood pressure values and Ang II levels. Although the mechanisms underlying this phenomenon are unclear, our experiment showed a link between renovascular hypertension and activation of kynurenine pathway. Impact statement As hypertension is a major health problem, our research has focused on the connection between the kynurenine pathway and hypertension. We assessed the levels of the main metabolites of dietary tryptophan and analyzed its levels in terms of high blood pressure. The results of our work indicated that in the renovascular rat's model of hypertension, an alteration of the kynurenine pathway occurred. According to our knowledge, this is the first study that has investigated in a comprehensive manner the alteration of the kynurenine pathway under the condition of elevated blood pressure. On the one hand, the work supports a better understanding of pathophysiological basics of the occurrence of hypertension, and on the other hand it provides potential opportunities to treat this disease.

Entities:  

Keywords:  2K1C Goldblatts’ model; Renovascular hypertension; angiotensin II; kynurenine pathway; rats; tryptophan metabolism

Mesh:

Substances:

Year:  2017        PMID: 28165296      PMCID: PMC5363689          DOI: 10.1177/1535370217693114

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  48 in total

1.  Acclimatization to hypoxia modulates the tryptophan 2,3-dioxygenase activity in rats exposed to simulated high altitude.

Authors:  M Yoshino; S Mori; M Nakatsuka; Y Shibata
Journal:  Comp Biochem Physiol B       Date:  1991

Review 2.  Endogenous kynurenines as targets for drug discovery and development.

Authors:  Trevor W Stone; L Gail Darlington
Journal:  Nat Rev Drug Discov       Date:  2002-08       Impact factor: 84.694

3.  Sex differences in the blood antioxidant defense system in juvenile rats with various genetic predispositions to hypertension.

Authors:  Martina Horvathova; Ingrid Zitnanova; Zuzana Kralovicova; Peter Balis; Angelika Puzserova; Jana Muchova; Michal Kluknavsky; Zdenka Durackova; Iveta Bernatova
Journal:  Hypertens Res       Date:  2015-10-29       Impact factor: 3.872

Review 4.  Kynurenic acid antagonists and kynurenine pathway inhibitors.

Authors:  T W Stone
Journal:  Expert Opin Investig Drugs       Date:  2001-04       Impact factor: 6.206

5.  Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo.

Authors:  Qiongxin Wang; Miao Zhang; Ye Ding; Qilong Wang; Wencheng Zhang; Ping Song; Ming-Hui Zou
Journal:  Circ Res       Date:  2013-11-26       Impact factor: 17.367

6.  A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.

Authors:  M P Heyes; K Saito; E O Major; S Milstien; S P Markey; J H Vickers
Journal:  Brain       Date:  1993-12       Impact factor: 13.501

7.  The effects of an inhibitor of tryptophan 2,3-dioxygenase and a combined inhibitor of tryptophan 2,3-dioxygenase and 5-HT reuptake in the rat.

Authors:  M Salter; R Hazelwood; C I Pogson; R Iyer; D J Madge; H T Jones; B R Cooper; R F Cox; C M Wang; R P Wiard
Journal:  Neuropharmacology       Date:  1995-02       Impact factor: 5.250

8.  Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by high-performance liquid chromatography.

Authors:  E W Holmes
Journal:  Anal Biochem       Date:  1988-08-01       Impact factor: 3.365

9.  Tryptophan-containing dipeptides are C-domain selective inhibitors of angiotensin converting enzyme.

Authors:  Diana Lunow; Susanne Kaiser; Jana Rückriemen; Christoph Pohl; Thomas Henle
Journal:  Food Chem       Date:  2014-06-18       Impact factor: 7.514

10.  The role of endogenous aryl hydrocarbon receptor signaling in cardiovascular physiology.

Authors:  Nan Zhang
Journal:  J Cardiovasc Dis Res       Date:  2011-04
View more
  12 in total

Review 1.  The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease.

Authors:  Hai Ning Wee; Jian-Jun Liu; Jianhong Ching; Jean-Paul Kovalik; Su Chi Lim
Journal:  Am J Nephrol       Date:  2021-11-09       Impact factor: 3.754

Review 2.  The Footprint of Kynurenine Pathway in Cardiovascular Diseases.

Authors:  Moein Ala; Seyed Parsa Eftekhar
Journal:  Int J Tryptophan Res       Date:  2022-06-28

3.  Quantification of IDO1 enzyme activity in normal and malignant tissues.

Authors:  Lijie Zhai; Erik Ladomersky; April Bell; Corey Dussold; Krislyn Cardoza; Jun Qian; Kristen L Lauing; Derek A Wainwright
Journal:  Methods Enzymol       Date:  2019-07-24       Impact factor: 1.600

Review 4.  Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.

Authors:  Ping Song; Tharmarajan Ramprasath; Huan Wang; Ming-Hui Zou
Journal:  Cell Mol Life Sci       Date:  2017-03-17       Impact factor: 9.261

5.  Establishment and evaluation of a reversible two-kidney, one-clip renovascular hypertensive rat model.

Authors:  Li-Qiang Li; Jian Zhang; Rong Wang; Jian-Xin Li; Yong-Quan Gu
Journal:  Exp Ther Med       Date:  2017-04-26       Impact factor: 2.447

Review 6.  Oxidative Storm Induced by Tryptophan Metabolites: Missing Link between Atherosclerosis and Chronic Kidney Disease.

Authors:  Iwona Kwiatkowska; Justyna M Hermanowicz; Michal Mysliwiec; Dariusz Pawlak
Journal:  Oxid Med Cell Longev       Date:  2020-12-29       Impact factor: 6.543

7.  Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease.

Authors:  Tomasz W Kaminski; Krystyna Pawlak; Malgorzata Karbowska; Michal Mysliwiec; Waldemar Grzegorzewski; Jakub Kuna; Dariusz Pawlak
Journal:  Int Urol Nephrol       Date:  2017-10-22       Impact factor: 2.370

8.  Sexual Dimorphism of Metabolomic Profile in Arterial Hypertension.

Authors:  Yaya Goïta; Juan Manuel Chao de la Barca; Asmaou Keïta; Mamadou Bocary Diarra; Klétigui Casimir Dembélé; Floris Chabrun; Boubacar Sidiki Ibrahim Dramé; Yaya Kassogué; Mahamadou Diakité; Delphine Mirebeau-Prunier; Bakary Mamadou Cissé; Gilles Simard; Pascal Reynier
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

Review 9.  Developmental Programming and Reprogramming of Hypertension and Kidney Disease: Impact of Tryptophan Metabolism.

Authors:  Chien-Ning Hsu; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

10.  Study of the Mechanism Underlying the Antihypertensive Effects of Eucommia ulmoides and Tribulus terrestris Based on an Analysis of the Intestinal Microbiota and Metabonomics.

Authors:  Ying-Zi Qi; Xue-Song Yang; Yue-Hua Jiang; Lin-Lin Shao; Ling-Yu Jiang; Chuan-Hua Yang
Journal:  Biomed Res Int       Date:  2020-11-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.